Methylene Blue in Severe Sepsis and Septic Shock

NCT01797978 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

354

Enrollment

OTHER

Sponsor class

Conditions

Severe Sepsis
Septic Shock

Interventions

DRUG: Intravenous methylene blue administration
DRUG: Placebo

Sponsor

Seoul National University Hospital